Diffuse Large B-Cell Lymphoma (DLBCL)
Also known as: Large Cell Lymphoma, Diffuse / Diffuse Large B Cell Lymphoma,DLBCL / Lymphoma Diffuse Large B-cell / Diffuse Large Cell Lymphoma / Diffuse Large B Cell Lymphoma, DLBCL / DLBCL / Diffuse Large-cell B-cell Lymphoma / Diffuse Large B-cell-lymphoma / Large B Cell Diffuse Lymphoma / DLBCL, Diffused Large B Cell Lymphoma / Diffuse Large B Lymphoma (DLBCL) / Large-B-cell Diffuse Lymphoma / Large B-cell Diffuse Lymphoma / Diffuse Large B-Cell Lymphoma Cell of Origin / Diffuse Large B Cell Lymphoma (DLBCL) / Diffuse Large B-cell Lymphoma(DLBCL) / Diffuse Large B Cell Lymphoma / DLBCL - Diffuse Large B Cell Lymphoma / Diffuse-large B-cell Lymphoma (DLBCL) / Diffuse Large B-Cell Lymphoma / Diffuse Large Cell B-lymphoma / Diffuse large B-cell lymphomas / Diffuse Large-Cell Lymphoma / Diffuse large B cell malignant lymphoma (morphologic abnormality) / Diffuse large B-cell lymphoma NOS / Diffuse large B-cell malignant lymphoma (disorder) / Lymphoma, Large B-Cell, Diffuse / Plasmablastic lymphoma (disorder) / Plasmablastic lymphoma / Plasmablastic lymphoma (morphologic abnormality) / Anaplastic diffuse large B-cell lymphoma (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|---|---|
DB16371 | Glofitamab | A bispecific monoclonal antibody directed against CD20 and CD3 which is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma. |
DB00070 | Hyaluronidase (ovine) | A purified form of sheep hyaluronidase enzyme used as an adjunct in subcutaneous rehydration therapy and to increase absorption of other drugs and radiopaque imaging agents. |
DB00073 | Rituximab | A monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis. |